Evidence map›Paper›PMID 35326482›Full record

ReviewCells2022

On the Cutting Edge of Oral Cancer Prevention: Finding Risk-Predictive Markers in Precancerous Lesions by Longitudinal Studies.

Madeleine Crawford, Eliza H Johnson, Kelly Y P Liu, Catherine Poh, Robert Y L Tsai

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Madeleine CrawfordInstitute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Eliza H JohnsonInstitute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Kelly Y P LiuFaculty of Dentistry, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Catherine PohFaculty of Dentistry, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Robert Y L TsaiInstitute of Biosciences and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.ORCID 0000-0002-8357-0812
Texas A&M Health Science Center · USUniversity of British Columbia · CA

Funding

Planning a Trial of Sulindac for Oral LeukoplakiaR21DE016390 · NIDCR · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BOYLE, JAY O · 2004 to 2005
$290k
Cancer Prevention and Research Institute of Texas RP170179NIDCR NIH HHS R21 DE016390
6 · The paper itself

Abstract

Early identification and management of precancerous lesions at high risk of developing cancers is the most effective and economical way to reduce the incidence, mortality, and morbidity of cancers as well as minimizing treatment-related complications, including pain, impaired functions, and disfiguration. Reliable cancer-risk-predictive markers play an important role in enabling evidence-based decision making as well as providing mechanistic insight into the malignant conversion of precancerous lesions. The focus of this article is to review updates on markers that may predict the risk of oral premalignant lesions (OPLs) in developing into oral squamous cell carcinomas (OSCCs), which can logically be discovered only by prospective or retrospective longitudinal studies that analyze pre-progression OPL samples with long-term follow-up outcomes. These risk-predictive markers are different from those that prognosticate the survival outcome of cancers after they have been diagnosed and treated, or those that differentiate between different lesion types and stages. Up-to-date knowledge on cancer-risk-predictive markers discovered by longitudinally followed studies will be reviewed. The goal of this endeavor is to use this information as a starting point to address some key challenges limiting our progress in this area in the hope of achieving effective translation of research discoveries into new clinical interventions.

Indexed as

Head and Neck NeoplasmsMouth NeoplasmsPrecancerous ConditionsHumansLongitudinal StudiesProspective StudiesRetrospective StudiesDNA methylationepigeneticgenetic mutationlong-term follow-uprisk assessmenttranslational study

Identifiers

PMID35326482
PMCPMC8947091
OpenAlexW4220808362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.